RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Yanchuang Capital
Y

Yanchuang Capital portfolio

Yanchuang Capital has 2 portfolio companies on record at Recent Funding.

Type: Investor.
Portfolio on Recent Funding: 2.
Deals, last 12 months: 0.
Capital in their rounds: $134M.
Latest deal: Laekna Therapeutics · May 18, 2022.
About this page

Its most recent investment on record is Laekna Therapeutics's $61M Series B+ round in May 2022, alongside HB Ventures, CS Capital, Infinity Capital and 2 others. By category, its portfolio leans toward Health and bio (2) and Education (1). It has co-invested with HB Ventures, CS Capital and Infinity Capital.

What Yanchuang Capital invests in

How Yanchuang Capital invests

StageDealsCapital in rounds
Series B+ 2 100%$134M
YearDealsCapital in rounds
2021 1 50%$73M
2022 1 50%$61M

Yanchuang Capital portfolio companies

CompanyRound with Yanchuang CapitalTotal raisedLatest raise
LLaekna Therapeutics
Health and bio
Series B+ · $61M$61MMay 18, 2022
Series B+
IImmune-Onc Therapeutics
Health and bio
Series B+ · $73M$211MJan 5, 2023
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 2 rounds on Recent Funding that name Yanchuang Capital. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Yanchuang Capital, which is a subset of its real portfolio. API: /api/v1/investors/yanchuang-capital (get a free API key). More: the most active VC firms and new venture capital funds.